<DOC>
	<DOC>NCT01130935</DOC>
	<brief_summary>This study will assess the effectiveness of Nexium at alleviating upper GI symptoms in subjects and evaluate with which treatment regimen and on which indications acid suppression with isomeric proton pump inhibitor is used in routine clinical practice in Albania.</brief_summary>
	<brief_title>Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium</brief_title>
	<detailed_description />
	<criteria>Subject must have had upper GI symptoms requiring acid suppression treatment Treatment with Nexium is in accordance with indications and dosing approved in Albania. Start of treatment at least 2 weeks prior to enrollment to this study 5. Written informed consent is signed. Known hypersensitivity to Nexium or any other constituents of the formulation Concomitant administration of atazanavir and nelfinavir. Alarming upper GI symptoms (i.e. significant unintended weight loss, vomiting, dysphasia, hematemesis, melena, fever, jaundice or any other sign indicating serious or malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>GERD</keyword>
	<keyword>gastric and duodenal ulcers</keyword>
	<keyword>NSAID therapy</keyword>
</DOC>